|

BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy

RECRUITINGPhase 3Sponsored by Braveheart Bio, Inc.
Actively Recruiting
PhasePhase 3
SponsorBraveheart Bio, Inc.
Started2026-09-02
Est. completion2028-10
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
Locations3 sites

Summary

The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of obstructive hypertrophic cardiomyopathy (oHCM). The trial includes adults who are currently being treated for oHCM or who have not yet been treated.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Key Inclusion Criteria:

* Diagnosed with oHCM per the protocol specified criteria
* NYHA Class II or III at screening visits
* KCCQ-CSS that meets the protocol specified criteria at screening visits
* Adequate acoustic windows for echocardiography

Key Exclusion Criteria:

* Medical indication for either β-blocker or calcium-channel blocker therapy, other than oHCM, prohibiting drug discontinuation
* History of intolerance or medical contraindication to β-blocker therapy
* Resting systolic blood pressure (SBP) of \>160 millimeters of mercury (mmHg) at screening visits
* Resting heart rate of \>100 beats per minute (bpm) at screening visits
* Significant valvular heart disease, defined as:

  * Moderate to severe valvular aortic stenosis or fixed subaortic obstruction;
  * Mitral regurgitation not due to systolic anterior motion of the mitral valve (per Investigator's judgment)

Other protocol-defined criteria apply.

Conditions2

Cardiomyopathy, Hypertrophic ObstructiveHeart Disease

Interventions2

Locations3 sites

New York

1 site
LIONHEART-HCM Site 0107
Manhasset, New York, 11030

South Carolina

1 site
LIONHEART-HCM Site 0126
Rock Hill, South Carolina, 29732

Texas

1 site
LIONHEART-HCM Site 0121
Plano, Texas, 75024

Find trials near these locations

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.